Learning Objectives:

1. To review the incidence and the morbidity of dystrophic cardiomyopathy.

2. To review current therapies for dystrophic cardiomyopathy.

3. To examine and highlight translational research models to examine new therapies.


Session date: 
04/30/2021 - 12:00pm to 1:00pm CDT
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Daniel Garry, MD, PhD